123 related articles for article (PubMed ID: 15680394)
21. Melanoma-associated antigens in esophageal adenocarcinoma: identification of novel MAGE-A10 splice variants.
Lin J; Lin L; Thomas DG; Greenson JK; Giordano TJ; Robinson GS; Barve RA; Weishaar FA; Taylor JM; Orringer MB; Beer DG
Clin Cancer Res; 2004 Sep; 10(17):5708-16. PubMed ID: 15355897
[TBL] [Abstract][Full Text] [Related]
22. Involvement of p53 and interleukin 3 in the up-regulation of CD95 (APO-1/Fas) by X-ray irradiation.
Gutiérrez del Arroyo A; Gil-Lamagniere C; Lazaro I; de Marco MC; Layunta I; Silva A
Oncogene; 2000 Jul; 19(32):3647-55. PubMed ID: 10951571
[TBL] [Abstract][Full Text] [Related]
23. Effect of C-terminal deletion of P53 on heat induced CD95 expression and apoptosis in a rat histiocytoma.
Sreedhar AS; Pardhasaradhi BV; Khar A; Srinivas UK
Oncogene; 2002 Jun; 21(25):4042-9. PubMed ID: 12037686
[TBL] [Abstract][Full Text] [Related]
24. Matrix metalloproteinases 9 and 10 inhibit protein kinase C-potentiated, p53-mediated apoptosis.
Meyer E; Vollmer JY; Bovey R; Stamenkovic I
Cancer Res; 2005 May; 65(10):4261-72. PubMed ID: 15899818
[TBL] [Abstract][Full Text] [Related]
25. Hypoxia induces p53-dependent transactivation and Fas/CD95-dependent apoptosis.
Liu T; Laurell C; Selivanova G; Lundeberg J; Nilsson P; Wiman KG
Cell Death Differ; 2007 Mar; 14(3):411-21. PubMed ID: 16917513
[TBL] [Abstract][Full Text] [Related]
26. Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis.
Huerta-Yepez S; Vega M; Garban H; Bonavida B
Clin Immunol; 2006 Sep; 120(3):297-309. PubMed ID: 16784892
[TBL] [Abstract][Full Text] [Related]
27. RUNX3 inhibits cell proliferation and induces apoptosis by reinstating transforming growth factor beta responsiveness in esophageal adenocarcinoma cells.
Torquati A; O'rear L; Longobardi L; Spagnoli A; Richards WO; Daniel Beauchamp R
Surgery; 2004 Aug; 136(2):310-6. PubMed ID: 15300196
[TBL] [Abstract][Full Text] [Related]
28. The breakdown of apoptotic mechanism in the development and progression of colorectal carcinoma.
Ogawa S; Nagao M; Kanehiro H; Hisanaga M; Ko S; Ikeda N; Nakajima Y
Anticancer Res; 2004; 24(3a):1569-79. PubMed ID: 15274324
[TBL] [Abstract][Full Text] [Related]
29. Enhanced gene transfer and cell death following p53 gene transfer using photochemical internalisation of glucosylated PEI-DNA complexes.
Ndoye A; Merlin JL; Leroux A; Dolivet G; Erbacher P; Behr JP; Berg K; Guillemin F
J Gene Med; 2004 Aug; 6(8):884-94. PubMed ID: 15293347
[TBL] [Abstract][Full Text] [Related]
30. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.
Idogawa M; Sasaki Y; Suzuki H; Mita H; Imai K; Shinomura Y; Tokino T
Clin Cancer Res; 2009 Jun; 15(11):3725-32. PubMed ID: 19458054
[TBL] [Abstract][Full Text] [Related]
31. Effect of p53 status and STAT1 on chemotherapy-induced, Fas-mediated apoptosis in colorectal cancer.
McDermott U; Longley DB; Galligan L; Allen W; Wilson T; Johnston PG
Cancer Res; 2005 Oct; 65(19):8951-60. PubMed ID: 16204068
[TBL] [Abstract][Full Text] [Related]
32. The molecular biology of esophageal adenocarcinoma.
Koppert LB; Wijnhoven BP; van Dekken H; Tilanus HW; Dinjens WN
J Surg Oncol; 2005 Dec; 92(3):169-90. PubMed ID: 16299787
[TBL] [Abstract][Full Text] [Related]
33. MAL gene expression in esophageal cancer suppresses motility, invasion and tumorigenicity and enhances apoptosis through the Fas pathway.
Mimori K; Shiraishi T; Mashino K; Sonoda H; Yamashita K; Yoshinaga K; Masuda T; Utsunomiya T; Alonso MA; Inoue H; Mori M
Oncogene; 2003 May; 22(22):3463-71. PubMed ID: 12776198
[TBL] [Abstract][Full Text] [Related]
34. Expression of the bile acid receptor FXR in Barrett's esophagus and enhancement of apoptosis by guggulsterone in vitro.
De Gottardi A; Dumonceau JM; Bruttin F; Vonlaufen A; Morard I; Spahr L; Rubbia-Brandt L; Frossard JL; Dinjens WN; Rabinovitch PS; Hadengue A
Mol Cancer; 2006 Oct; 5():48. PubMed ID: 17054793
[TBL] [Abstract][Full Text] [Related]
35. Phosphorylated and hypoacetylated mutant p53 enhances cisplatin-induced apoptosis through caspase-9 pathway in the absence of transcriptional activation or translation.
Lai MD; Lin WC; Sun YM; Chang FL
Int J Mol Med; 2005 Apr; 15(4):725-34. PubMed ID: 15754039
[TBL] [Abstract][Full Text] [Related]
36. Commentary on "Bile salts differentially sensitize esophageal squamous cells to CD95 (Fas/Apo-1 receptor) mediated apoptosis".
Bland KI
J Surg Res; 2011 Jun; 168(1):31-3. PubMed ID: 20869079
[No Abstract] [Full Text] [Related]
37. Cooperation of two mutant p53 alleles contributes to Fas resistance of prostate carcinoma cells.
Gurova KV; Rokhlin OW; Budanov AV; Burdelya LG; Chumakov PM; Cohen MB; Gudkov AV
Cancer Res; 2003 Jun; 63(11):2905-12. PubMed ID: 12782597
[TBL] [Abstract][Full Text] [Related]
38. Fast neutrons-induced apoptosis is Fas-independent in lymphoblastoid cells.
Fischer B; Benzina S; Jeannequin P; Dufour P; Bergerat JP; Denis JM; Gueulette J; Bischoff PL
Biochem Biophys Res Commun; 2005 Aug; 334(2):533-42. PubMed ID: 16018969
[TBL] [Abstract][Full Text] [Related]
39. E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells.
Rampias T; Sasaki C; Weinberger P; Psyrri A
J Natl Cancer Inst; 2009 Mar; 101(6):412-23. PubMed ID: 19276448
[TBL] [Abstract][Full Text] [Related]
40. Mutant p53 gain of function: repression of CD95(Fas/APO-1) gene expression by tumor-associated p53 mutants.
Zalcenstein A; Stambolsky P; Weisz L; Müller M; Wallach D; Goncharov TM; Krammer PH; Rotter V; Oren M
Oncogene; 2003 Aug; 22(36):5667-76. PubMed ID: 12944915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
